Infectious Diseases
Should Not Kill Anyone
Universal Infectious Diseases Test (UID)
A Revolutionary Technology to Aid the Clinician
Sepsis And Its Global Impact
Sepsis is the body's extreme response to an infection and is potentially life-threatening. This occurs when a pre-existing infection
triggers a chain reaction throughout your body, often leading to shock, disability, multi organ failure, or even death.
SEPSIS IS A LEADING CAUSE OF DEATH
- Sepsis 11Mn
- TB 1.5Mn
- Cancer 10Mn
- Stroke 6Mn
>2 BILLION PEOPLE WITH THE FOLLOWING PRE-EXISTING
CONDITIONS ARE AT A HIGHER RISK OF SEPSIS
The Universal Infectious Diseases Test
UID Test is an NGS based culture-free test to identify causative pathogen in a quick turn around time
1200+ PATHOGENS
Comprehensive single screening test covering bacteria and fungi
ARG PROFILING
Identifies drug resistance based on Antibiotic Resistance Gene (ARG) profile
RESULT REPORTED IN < 12 HOURS
Hands on time < 4 hours
The Current System Needs An Upgrade To Save Lives
| Tests for ID | Turn Around Time | Pathogen Coverage | Antibiotic Coverage | Additional Information |
|---|---|---|---|---|
 UID Test |  12 hours | >1200 pathogens | ARGs | Species and Genus identification |
 Culture Test | 2-10 Days | Culturable bacteria and fungi | Selected Panel | |
 Molecular Test | 12-24 Hours | Up to 43 pathogens | 1-5 Antibiotics | Upgradation of technology on existing set up is not possible or is very difficult |
Our Partners
100+
CITIES
100+
HOSPITALS
500+
DOCTORS
How may we help you?
In the news
24 April 2022 | The Times of India
COVID-19 led to a spike in Tuberculosis cases in India: Experts
March 24 is globally observed as World Tuberculosis Day every year to raise awareness about the disease that is curable but affects approximately 4.1
24 March 2022 | Medgate today Magazine
Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 - HaystackAnalytics Insights
A staggering 65% of the Tuberculosis cases in India are in the 15-45 age group Mortality numbers due to Tuberculosis in India are more than other South Asian neighbours a Mumbai based health-tech startup, supported by the...
7 February 2022 | The Economic Times
HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test
Chennai: Healthtech startup HaystackAnalytics on Monday said it has developed India’s first Universal Infectious Disease (ID) genomic test, claiming to make it the world’s first company to bring genomics based infectious diseases diagnostic to hospitals. Read more at: https://economictimes.indiatimes.com/tech/technology/haystackanalytics-develops-first-universal-infectious-disease-id-genomic-test/articleshow/89405780.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
22 January 2022 | Financial Express
Public Health: Tech a formidable ally against TB
Tuberculosis (TB) is one of India’s foremost public health problems. As per World Health Organisation (WHO) estimates, India has the highest burden of TB in the world. In 2021, the country witnessed a 19% upsurge in TB cases over the previous year. Despite having an aggressive TB control programme in place, drug resistance has led to the country witnessing a sharp increase in the number of cases over the last decade. By recent estimates, 75% of drug-resistant TB (DR-TB) cases remain undiagnosed, with such patients actively transmitting the disease. Diagnosing DR-TB at an early stage is a major challenge, as it can take up to three months to detect it using existing approaches. This is where genome sequencing comes in, as it enables early and accurate diagnosis of such diseases and helps cut the costs of diagnosis and therapy.
Awards & Recognition
